Company news
Correvio Pharma Corp news in 2015
Correvio Pharma Corp's news releases, calls and decks from 2015, newest first.
Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant
December 22, 2015
Cardiome Reports Third Quarter 2015 Financial Results
November 13, 2015
Cardiome to Hold Third Quarter 2015 Financial Results Conference Call on November 13
November 6, 2015
Cardiome announces addition of Robert James Meyer, M.D. to board of directors
September 8, 2015
Cardiome to Present at the 17th Annual Rodman & Renshaw Global Investment Conference
August 27, 2015
Cardiome Expands Partnership with Eddingpharm to Commercialize AGGRASTAT in China
August 24, 2015
United Kingdom Department of Health Sets BRINAVESS Pricing
August 10, 2015
Cardiome Reports Second Quarter 2015 Financial Results
August 5, 2015
Cardiome to Hold Second Quarter 2015 Financial Results Conference Call on August 5
July 28, 2015
Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China
July 24, 2015
Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada
July 22, 2015
Cardiome to Present at JMP Securities Healthcare Conference
June 16, 2015
Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation
June 12, 2015
Cardiome Appoints David Dean Vice President, Business Development and Investor Relations
June 3, 2015
Cardiome Reports First Quarter 2015 Financial Results
May 13, 2015
Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement
May 12, 2015
Cardiome To Hold First Quarter 2015 Financial Results Conference Call On May 13
May 7, 2015
Cardiome to Present at Bloom Burton & Co. Healthcare Investor Conference
April 27, 2015
Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities
April 9, 2015
Cardiome reports fourth quarter and full year 2014 financial results
March 12, 2015
Cardiome to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on March 12
March 5, 2015